News
November 10, 2022
AI Review Tool "KIBIT Automator"
Improved Landscaping and Precision Algorithms
AI Supports Strategic Efforts During Early Review Stages
February 15, 2017
November 12, 2024
FRONTEO, Inc. (Head Office: Minato-ku, Tokyo; President and CEO: Masahiro Morimoto; hereafter "FRONTEO") is pleased to announce that an agreement has been reached to provide Daiichi Sankyo Co., Ltd. (Head Office: Chuo-ku, Tokyo; President and COO: Hiroyuki Okuzawa; hereafter "Daiichi Sankyo") with analysis services using Drug Discovery AI Factory (hereafter "DDAIF")* to analyze text information from toxicity study databases and reports.
January 20, 2023
Earlier in 2022, FRONTEO was pleased to announce the release of its proprietary e-Discovery hosting platform called KIBIT Automator Review or KAMR.
January 12, 2024
FRONTEO is a proud sponsor of Legalweek 2024 at the New York Hilton Midtown – January 29th – February 1st. Come join your peers in the legal profession at this annual gathering.
April 11, 2023
Chat applications text, which has been used more due to the COVID-19 pandemic, can be analyzed
August 4, 2021
NEW YORK, August 4, 2021 – FRONTEO (TSE: 2158) announced that our AI review tool "KIBIT Automator" was used for an investigative case of unauthorized access and removal of confidential information in the United States.
October 12, 2021
FRONTEO USA launched a new website on its Life Science business, which is drawing attention.
Under the title of “Equal Medical Care for Everybody with AI”, we introduce our AI system powered by “Concept Encoder”, the natural language analysis specialized in the Life Science fields below.
February 29, 2024
FRONTEO, Inc. (Headquarters: Minato-ku, Tokyo; President & CEO: Masahiro Morimoto) is hosting a free seminar “Recent Developments in AI and Competition Law – a Global Perspective” in collaboration with White & Case LLP on March 19th.
April 15, 2020
November 10, 2023
FRONTEO Inc. (Headquarters: Minato-ku, Tokyo; President & CEO: Masahiro Morimoto; hereinafter “FRONTEO”) and Axcelead Drug Discovery Partners Inc. (Headquarters: Fujisawa City, Kanagawa Prefecture; President: Nobuhiko Yamada; hereinafter “Axcelead DDP”) have entered into a master collaboration agreement for AI drug discovery support.
January 30, 2024
We have enhanced our existing forensic services with new cutting-edge digital forensics software package, and we are working on adding more certified forensic experts to our staff.
September 9, 2022
U.S.-based lawyers with extensive experience explain the latest litigation cases and trends for Japanese companies
June 6, 2023
Revolutionary AI Harnesses the Power of Human Intuition in Core Technologies
February 15, 2022
Fronteo hits 6,000 subscriber milestone thanks to variety of video lectures delivered by over one hundred highly acclaimed legal experts in Japan and the U.S.
January 28, 2025
Accelerate First in Class R&D with FRONTEO’s unique technologies that systematically discover unreported relationships between diseases and molecules from existing literature information.
February 6, 2024
Enhanced function of the Drug Discovery AI Factory, analyze cutting-edge academic articles to propose highly novel target molecules and hypotheses
November 2, 2021
KIBIT Automator, an AI-based e-discovery and digital forensics platform, runs on Microsoft Azure, the world's most secure environment.